MUSK and myasthenia gravis: Hoch and colleagues (Hoch et al., 2001) detected the antibodies against MuSK (as discussed later, two types of antibodies are determined: Y2 targeting the Ig1/2 domains and Y3 targeting CRD in Figure 1) in the serum samples of MG patients without AChR antibodies.